“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Disability Rights are Human Rights
The 'Red Pill' Of Economics
DARPA Manager Explains Multiple Ways Cars Can Be Hacked And Completely Taken Over
Man arrested, charged with theft for plugging car into school’s outlet
New York police brutally beat man for sleeping at synagogue
Syrians In Ghouta Claim Saudi-Supplied Rebels Behind Chemical Attack
National I.D. By Any Other Name Still Stinks
Hong Kong 2012 net gold flow to China hit record high
Fayette man accuses police in Roane County of brutalizing him
Homeland Security retains black race warrior
Who Gave Hollywood's Representatives the Same Exact DMCA Question?
Egyptian ministers resign in wave as Army deadline nears
The CFR: The Go-To Organization for Government Tools Ready to Cash In
Wisconsin GOP lawmakers support arresting federal officials over Obamacare
Flood of Teenage Immigrants? The DHS's Solution: ID Card Compliance